Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04589442 · ClinicalTrials.gov registry record · Phase 4
Microsurfaced Grafts in Deep Burn Wounds
A Phase 4 study of Burns and Wound Heal, sponsored by CellTherX.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04589442: Recruiting Phase 4 study of Burns and Wound Heal, sponsored by CellTherX.
NCT04589442 is a Phase 4 study of Burns and Wound Heal that is actively recruiting participants, run by CellTherX. The registered enrollment target is 20 participants, below the 83-participant average among 36 other Burns trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04589442, a Phase 4 study of Burns and Wound Heal, is actively recruiting participants, sponsored by CellTherX.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed as a prospective, randomized, within subject controlled design to evaluate the effectiveness of Microsurfaced vs Control cadaveric grafts for coverage of acute deep-partial or full-thickness burn wounds to promote wound healing. This study will be performed in 2 parts: Time to wound bed preparedness through 6 weeks (Part A) and wound site healing, graft take and long-term scar outcomes (Part B). Subjects will be treated with both control and microsurfaced cadaveric grafts on adjacent deep-partial or full-thickness burn wounds.
Primary Outcome
To compare wound bed preparedness/time to autograft in deep-partial and full thickness burns and burn wound healing in partial thickness burns in burn sites treated with Microsurfaced vs Control cadaveric graft-treated groups through 6 weeks post initial injury.
Conditions Studied
Interventions
- BIOLOGICAL Split thickness skin graft
- BIOLOGICAL microsurfaced split thickness skin graft
Study Locations (1)
Georgia
- Joseph M Still Research Foundation - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-01-04 |
| Est. Completion | 2021-12 |
| Phase | Phase 4 |
What NCT04589442 shows while recruiting
NCT04589442 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 83-participant average among 36 other Burns trials with a reported enrollment target (76% lower).
The record links to 2 conditions, with Burns appearing as the primary indexed condition, and to 2 interventions - of which Split thickness skin graft is the first listed.
NCT04589442 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT04589442 about?
NCT04589442 is a clinical study titled "Microsurfaced Grafts in Deep Burn Wounds". This study is designed as a prospective, randomized, within subject controlled design to evaluate the effectiveness of Microsurfaced vs Control cadaveric grafts for coverage of acute deep-partial or full-thickness burn wounds to promote wound healing. This study will be performed in 2 parts: Time to...
What is the current status of trial NCT04589442?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2021-01-04. Estimated completion is 2021-12.
What conditions does trial NCT04589442 study?
This clinical trial studies the following conditions: Burns, Wound Heal.
What interventions are being tested in trial NCT04589442?
The interventions under investigation include: Split thickness skin graft (BIOLOGICAL), microsurfaced split thickness skin graft (BIOLOGICAL).
Who is sponsoring clinical trial NCT04589442?
This trial is sponsored by CellTherX, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04589442 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Burns
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04589442's enrollment target sits among peer trials
20 23rd of 36 higher than 11 of 36 other Burns trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Burns trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
RECRUITING · Phase 4
-
Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers
RECRUITING · Phase 4
-
Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft
RECRUITING · Phase 4
-
Comparison of Wound Bed Establishment in Facial Burns
COMPLETED · Phase 4
-
Suprathel® Use During Prolonged Field Care to Promote Healing and Reduce the Need for Grafting of Burn Wounds
RECRUITING · NA
-
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI